These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28695555)

  • 1. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project.
    Morell S; Hemmeler C; Amsler F; Gross T
    Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term persistence with anti-osteoporosis drugs after fracture.
    Klop C; Welsing PM; Elders PJ; Overbeek JA; Souverein PC; Burden AM; van Onzenoort HA; Leufkens HG; Bijlsma JW; de Vries F
    Osteoporos Int; 2015 Jun; 26(6):1831-40. PubMed ID: 25822104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of osteoporosis following fragility fractures of the distal radius in a large health maintenance organization.
    Benzvi L; Gershon A; Lavi I; Wollstein R
    Arch Osteoporos; 2016; 11():20. PubMed ID: 27142832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture.
    Iba K; Takada J; Hatakeyama N; Kaya M; Isogai S; Tsuda H; Obata H; Miyano S; Yamashita T
    J Orthop Sci; 2006 Oct; 11(5):446-9. PubMed ID: 17013730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
    Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
    Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.
    Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY
    Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
    Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
    Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011.
    Dehamchia-Rehailia N; Ursu D; Henry-Desailly I; Fardellone P; Paccou J
    Osteoporos Int; 2014 Oct; 25(10):2409-16. PubMed ID: 24980182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patient- vs Physician-Reported Implementation of and Compliance to Anti-Osteoporotic Medication One Year after Sustained Fragility Fracture].
    Gross T
    Praxis (Bern 1994); 2018; 107(11):573-584. PubMed ID: 29788846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of osteoporotic refractures in regional Australia.
    Davidson E; Seal A; Doyle Z; Fielding K; McGirr J
    Aust J Rural Health; 2017 Dec; 25(6):362-368. PubMed ID: 28618161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk.
    Degli Esposti L; Girardi A; Saragoni S; Sella S; Andretta M; Rossini M; Giannini S;
    Endocrine; 2019 May; 64(2):367-377. PubMed ID: 30515678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
    Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
    Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention of minor trauma fractures: the effects of a tailored intervention-an observational study.
    van der Vet PCR; Kusen JQ; Rohner-Spengler M; Link BC; Houwert RM; Babst R; Henzen C; Schmid L; Beeres FJP
    Arch Osteoporos; 2019 Mar; 14(1):44. PubMed ID: 30923963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance to The Joint Commission proposed Core Measure set on osteoporosis-associated fracture: review of different secondary fracture prevention programs in an open medical system from 2010 to 2015.
    Fojas MC; Southerland LT; Phieffer LS; Stephens JA; Srivastava T; Ing SW
    Arch Osteoporos; 2017 Dec; 12(1):16. PubMed ID: 28155141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture.
    Flais J; Coiffier G; Le Noach J; Albert JD; Faccin M; Perdriger A; Thomazeau H; Guggenbuhl P
    Arch Osteoporos; 2017 Dec; 12(1):24. PubMed ID: 28251468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Naranjo A; Ojeda-Bruno S; Bilbao-Cantarero A; Quevedo-Abeledo JC; Diaz-González BV; Rodríguez-Lozano C
    Osteoporos Int; 2015 Nov; 26(11):2579-85. PubMed ID: 26048675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands.
    van den Berg P; Schweitzer DH; van Haard PM; van den Bergh JP; Geusens PP
    Osteoporos Int; 2015 Sep; 26(9):2257-63. PubMed ID: 25860976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Gamboa A; Duaso E; Marimón P; Sandiumenge M; Escalante E; Lumbreras C; Tarrida A
    Osteoporos Int; 2018 Oct; 29(10):2309-2314. PubMed ID: 30076454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent Patterns of Antifracture Medication Use Following Fracture on Therapy: A Population-Based Cohort Study.
    Kline GA; Morin SN; Lix LM; Leslie WD
    J Clin Endocrinol Metab; 2022 Jan; 107(2):491-499. PubMed ID: 34555165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.